NOVONIX Ltd Files Form 6-K for October 2024

Ticker: NVNXF · Form: 6-K · Filed: Oct 11, 2024 · CIK: 1859795

Sentiment: neutral

Topics: reporting, foreign-private-issuer, asx-announcement

Related Tickers: NVX

TL;DR

NOVONIX filed a 6-K, check the ASX announcement for news.

AI Summary

NOVONIX Limited filed a Form 6-K on October 11, 2024, reporting for the month of October 2024. The filing indicates that NOVONIX Limited is a foreign private issuer and will file its annual reports under Form 20-F. The document includes an Exhibit Index, with Exhibit 99.1 being an ASX Announcement.

Why It Matters

This filing provides an update on NOVONIX Limited's reporting status as a foreign private issuer and includes an ASX announcement, which may contain material information for investors.

Risk Assessment

Risk Level: low — This is a routine reporting form for a foreign private issuer and does not appear to contain significant new financial or operational disclosures.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the issuer has made or is required to make public in its home country.

Which annual report form does NOVONIX Limited file?

NOVONIX Limited files its annual reports under cover of Form 20-F.

What is included in the Exhibit Index of this filing?

The Exhibit Index lists Exhibit 99.1 as an ASX Announcement.

What is the principal executive office address of NOVONIX Limited?

The principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.

What is the filing date of this Form 6-K?

This Form 6-K was filed on October 11, 2024.

Filing Stats: 194 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-10-11 16:44:04

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: October 11, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing